Department of Obstetrics and Gynecology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 0114, USA; Vincent Center for Reproductive Biology, Massachusetts General Hospital, Boston, MA, 02114, USA.
Department of Obstetrics and Gynecology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 0114, USA.
Placenta. 2023 Sep 7;140:100-108. doi: 10.1016/j.placenta.2023.08.001. Epub 2023 Aug 6.
Maternal obesity is associated with increased risk of offspring obesity and cardiometabolic disease. Altered fetoplacental immune programming is a potential candidate mechanism. Differences in fetal placental macrophages, or Hofbauer cells (HBCs), have been observed in maternal obesity, and lipid metabolism is a key function of resident macrophages that may be deranged in inflammation/immune activation. We sought to test the following hypotheses: 1) maternal obesity is associated with altered HBC density and phenotype in the term placenta and 2) obesity-associated HBC changes are associated with altered placental lipid transport to the fetus. The impact of fetal sex was evaluated in all experiments.
We quantified the density and morphology of CD163-and CD68-positive HBCs in placental villi in 34 full-term pregnancies undergoing cesarean delivery (N = 15, maternal BMI ≥30 kg/m; N = 19, BMI <30 kg/m). Antibody-positive cells in terminal villi were detected and cell size and circularity analyzed using a semi-automated method for thresholding of bright-field microscopy images (ImageJ). Placental expression of lipid transporter genes was quantified using RTqPCR, and cord plasma triglycerides (TGs) were profiled using modified Wahlefeld method. The impact of maternal obesity and fetal sex on HBC features, lipid transporters, and cord TGs were evaluated by two-way ANOVA. Spearman correlations of cord TGs, HBC metrics and gene expression levels were calculated.
Maternal obesity was associated with significantly increased density of HBCs, with male placentas most affected (fetal sex by maternal obesity interaction p = 0.04). CD163+ HBCs were larger and rounder in obesity-exposed male placentas. Sexually dimorphic expression of placental FATP4, FATP6, FABPPM, AMPKB1 and AMPKG and cord TGs was noted in maternal obesity, such that levels were higher in males and lower in females relative to sex-matched controls. Cord TGs were positively correlated with HBC density and FATP1 expression.
Maternal obesity is associated with sex-specific alterations in HBC density and placental lipid transporter expression, which may impact umbilical cord blood TG levels and offspring cardiometabolic programming.
母体肥胖与后代肥胖和心脏代谢疾病的风险增加有关。改变胎儿胎盘免疫编程是一个潜在的候选机制。在母体肥胖中观察到胎儿胎盘巨噬细胞或 Hofbauer 细胞(HBC)的差异,脂质代谢是驻留巨噬细胞的关键功能,其在炎症/免疫激活中可能会失调。我们试图检验以下假设:1)母体肥胖与足月胎盘中 HBC 密度和表型的改变有关,2)肥胖相关的 HBC 变化与胎盘向胎儿转运脂质的改变有关。所有实验都评估了胎儿性别。
我们在 34 例接受剖宫产的足月妊娠(N=15,母亲 BMI≥30kg/m;N=19,BMI<30kg/m)中定量了胎盘绒毛中 CD163 和 CD68 阳性 HBC 的密度和形态。使用用于明场显微镜图像阈值的半自动方法(ImageJ)检测末端绒毛中的抗体阳性细胞,并分析细胞大小和圆度。使用 RTqPCR 定量胎盘脂质转运基因的表达,并使用改良的 Wahlefeld 方法对脐带血浆甘油三酯(TGs)进行分析。通过双因素方差分析评估母体肥胖和胎儿性别对 HBC 特征、脂质转运蛋白和脐带 TGs 的影响。计算脐带 TGs、HBC 指标和基因表达水平的Spearman 相关性。
母体肥胖与 HBC 密度显著增加有关,肥胖暴露的男性胎盘受影响最大(母体肥胖与胎儿性别相互作用 p=0.04)。肥胖暴露的男性胎盘中 CD163+HBC 更大且更圆。在母体肥胖中,胎盘 FATP4、FATP6、FABPPM、AMPKB1 和 AMPKG 和脐带 TGs 的性别二态性表达明显,与性别匹配的对照组相比,男性的水平较高,女性的水平较低。脐带 TGs 与 HBC 密度和 FATP1 表达呈正相关。
母体肥胖与 HBC 密度和胎盘脂质转运蛋白表达的性别特异性改变有关,这可能影响脐血 TG 水平和后代心脏代谢编程。